StoneX Group Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 913760 New York, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$555,574

+$326,404 QoQ

Shares Held

891

+308.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#768

of 1,297 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

StoneX Group Inc. holds $4,694,879 across 48 Biotechnology names. REGN ranks #2 (11.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,066	$1,026,244
2	REGN	Regeneron Pharmaceuticals, Inc. This page	891	$555,574
3	PRAX	Praxis Precision Medicines, Inc.	1,521	$509,215
4	HALO	Halozyme Therapeutics, Inc.	5,845	$457,488
5	HRMY	Harmony Biosciences Holdings, Inc.	12,149	$442,345
6	BBIO	BridgeBio Pharma, Inc.	3,888	$289,578
7	CRSP	CRISPR Therapeutics AG	4,133	$225,413
8	REPL	Replimune Group, Inc.	10,770	$119,223

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$555,574	891	+308.7%	Shares	Defined	2026-08-12
2024-09-30	$229,170	218	-7.2%	Shares	Defined	2025-08-13
2024-03-31	$226,185	235	-15.2%	Shares	Defined	2025-08-13
2023-12-31	$243,286	277	+10.8%	Shares	Defined	2025-08-13
2023-09-30	$205,740	250	-25.1%	Shares	Defined	2025-08-13
2023-03-31	$274,437	334	-18.5%	Shares	Defined	2025-08-13
2022-03-31	$286,352	410	+8.8%	Shares	Defined	2025-08-13
2021-12-31	$238,083	377	-21.6%	Shares	Defined	2025-08-13
2021-09-30	$291,091	481	-1.2%	Shares	Defined	2021-10-20
2021-06-30	$272,008	487	+2.1%	Shares	Defined	2021-08-06
2021-03-31	$225,687	477	-6.3%	Shares	Defined	2021-06-30
2020-12-31	$245,902	509	+1.0%	Shares	Defined	2021-02-03
2020-09-30	$282,129	504	+4.8%	Shares	Defined	2020-11-12
2020-06-30	$299,975	481	-5.9%	Shares	Defined	2020-08-12
2020-03-31	$249,516	511	—	Shares	Defined	2020-04-30
No filing history on record for this holder in this stock.